SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies, today ...
After seeing the successes of the likes of Pfizer (PFE) and Moderna (MRNA) in the news practically every day during this second year of the pandemic, the casual observer could be forgiven for assuming ...
It’s the time of year when we all get a little sentimental. We’re wrapping up work so we can shift to wrapping presents for under the tree. At Fierce Biotech, it’s no different. If you don’t know me, ...
(RTTNews) - In the healthcare sector, more than 160 companies went public on the U.S. stock exchanges this year through traditional IPO. Listed below are the biotech stocks that delivered at least 200 ...
Every time Andrew publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, today in ...
BioNTech should continue winning with Comirnaty and key pipeline advances. Eli Lilly has multiple growth drivers plus key FDA decisions on the way. Novavax has multiple near-term catalysts with ...
Even a second year of business interruptions caused by the COVID-19 pandemic couldn’t slow North Carolina’s bioscience juggernaut in 2021. Nineteen major expansions, relocations or new facilities ...
Welcome to The TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here.
Investor's Business Daily on MSN
Biotech stocks' dark winter is over. What that means for investors.
The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...
Biotech investor Brad Loncar shared with Insider his 10 predictions for 2022. He expected a rebound for biotech stocks after a down year in 2021. He also predicted hot research areas, which CEOs could ...
24/7 Wall St. on MSN
Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly Positioned
Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback